Dementia expert says evidence behind Biogen Alzheimer's drug 'wasn’t sufficient' for FDA approval

"Desperation should drive funding for Alzheimer's research, it should not drive the interpretation of scientific evidence," Karlawish said.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.